|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Product revenue, net | ||||
| Operating expenses: | ||||
| Cost of sales | ||||
| Cost of sales - inventory impairment and loss on firm purchase commitments | ||||
| Acquired in-process research and development | ||||
| Research and development | ||||
| Selling, general and administrative | ||||
| Restructuring expenses | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Other income, net: | ||||
| Interest income | ||||
| Other expense, net | ||||
| Total other income, net | ||||
| Loss before income taxes | ||||
| Provision (benefit) for income taxes | ||||
| Net loss | ||||
| Net loss per share - basic | ||||
| Net loss per share - diluted | ||||
| Weighted-average shares used in computing net loss per share - basic | ||||
| Weighted-average shares used in computing net loss per share - diluted |
Loading...
